aurizon
vetoquinol - clotrimazole 10 mg/ml, dexamethasone acetate 1 mg/ml, marbofloxacin 3 mg/ml - ear drops, suspension - dogs - dexamethasone and antiinfectives
aurizon
vetoquinol - clotrimazole 10 mg/ml, dexamethasone acetate 1 mg/ml, marbofloxacin 3 mg/ml - ear drops, suspension - dogs - dexamethasone and antiinfectives
aurizon
vetoquinol - clotrimazole 10 mg/ml, dexamethasone acetate 1 mg/ml, marbofloxacin 3 mg/ml - ear drops, suspension - dogs - dexamethasone and antiinfectives
aurizon
vetoquinol - clotrimazole 10 mg/ml, dexamethasone acetate 1 mg/ml, marbofloxacin 3 mg/ml - ear drops, suspension - dogs - dexamethasone and antiinfectives
aurizon
vetoquinol new zealand limited - clotrimazole; dexamethasone present as dexamethasone acetate; marbofloxacin - clotrimazole 10 g/litre; dexamethasone present as dexamethasone acetate 1 g/litre; marbofloxacin 3 g/litre - antifungal
clotrimazole and betamethasone dipropionate cream
proficient rx lp - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum . effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream in the treatment of infections caused by microsporum canis have been reported clotrimazole and betamethasone dipropionate cream is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or i
clotrimazole lozenge
hikma pharmacuticals usa usa inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg - clotrimazole is indicated for the local treatment of oropharyngeal candidiasis. the diagnosis should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole is also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole is contraindicated in patients who are hypersensitive to any of its components. no data available.
clotrimazole and betamethasone dipropionate lotion
e. fougera & co. a division of fougera pharmaceuticals inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 ml - clotrimazole and betamethasone dipropionate lotion is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum . effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate lotion for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. clotrimazole and betamethasone dipropionate lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or imidazoles, or to any ingredient in these preparations.
clotrimazole and betamethasone dipropionate cream clotrimazole and betamethasone dipropionate lotion
physicians total care, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream and lotion are indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes and trichophyton rubrum. effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream or lotion for the treatment of infections caused by zoophilic dermatophytes (e.g. microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream, usp in the treatment of infections caused by microsporum canis have been reported. clotrimazole and betamethasone dipropionate cream or lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dip
clotrimazole and betamethasone dipropionate cream
rebel distributors corp - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream and lotion are indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes and trichophyton rubrum. effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream or lotion for the treatment of infections caused by zoophilic dermatophytes (e.g. microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream, usp in the treatment of infections caused by microsporum canis have been reported. clotrimazole and betamethasone dipropionate cream or lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipr